Eli Lilly is set to post earnings Thursday morning, with the stock seen potentially sinking to its lowest level in months ...
Eli Lilly alleged that Empower lured customers away from their brand-name GLP-1 products and toward the pharmacy's ...
Stocktwits on MSN
VKTX shares drop after hours on larger Q1 losses but retail eyes the launch of its obesity pipeline
The company posted a Q1 net loss of $158.3 million, or $1.37 per share — more than triple the $45.6 million loss reported in the year-ago period. ・Viking ended the quarter with $603 million in cash, ...
But direct-to-patient drug sales can help with make more affordable, argue HealthDyne’s David Skomo and Sarah Thomas ...
Purdue University receives $20 million to establish the Purdue Institute for Healthcare Systems Innovation, aiming to improve ...
Leqembi, which was approved in 2023 to treat the mind-robbing disease, generated $168 million in sales, up 74 percent from ...
The YMCA of Greater Houston hosted its annual Dancing with Silver Stars event Wednesday at the Bayou City Event Center. In ...
Eli Lilly is set to report first-quarter results before the market opens Thursday. Here is what you need to know. PROFIT: The pharmaceutical company is projected to post a profit of $6.61 billion, ...
The president of the Back Bay real estate investment trust BXP said “there’s no question” that demand for life sciences lab ...
The Canadian government authorized a generic version of Ozempic developed by Dr. Reddy's Laboratories, making it the first G7 ...
Eli Lilly and Co. is taking another step to bolster its genetic medicine portfolio, this time through a $2.25 billion deal ...
Through two pioneering studies, Amgen and AstraZeneca will share study data with FDA scientists as it’s accrued. Elsewhere, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results